Tyrosine phosphorylation of DEPTOR functions as a molecular switch to activate mTOR signaling

Autor: Nicolas Bisson, Frédérick A. Mallette, Laurence M. Gagné, Marc-Étienne Huot, Jean-Philippe Lambert, Nadine Morin, Noémie Lavoie
Jazyk: angličtina
Rok vydání: 2021
Předmět:
PTM
post-translational modification

mTORC1
Biochemistry
mTORC2
chemistry.chemical_compound
0302 clinical medicine
EPHB2
Phosphorylation
CIP
calf intestinal alkaline phosphatase

0303 health sciences
biology
mTOR
mechanistic target of rapamycin

TOR Serine-Threonine Kinases
mTORC2
mTOR complex 2

Intracellular Signaling Peptides and Proteins
IP
immunoprecipitation

3. Good health
Cell biology
030220 oncology & carcinogenesis
mTOR
Research Article
Signal Transduction
Fer
Feline sarcoma–related protein

DEPTOR
FRQS
Fonds de Recherche du Québec—Santé

R-2HG
R-2-hydroxyglutarate

SYK
spleen tyrosine kinase

03 medical and health sciences
Humans
Molecular Biology
Protein kinase B
Mechanistic target of rapamycin
PI3K/AKT/mTOR pathway
030304 developmental biology
tyrosine phosphorylation
EPH
erythropoietin-producing hepatocellular carcinoma

Tyrosine phosphorylation
Cell Biology
Tyr
tyrosine

PTEN
phosphatase and tensin homolog

HEK293 Cells
chemistry
biology.protein
β-TRCP1
β-transducin repeat–containing protein 1

Tyrosine
mTORC1
mTOR complex 1

Protein Processing
Post-Translational

HA
hemagglutinin

HeLa Cells
Zdroj: The Journal of Biological Chemistry
ISSN: 1083-351X
0021-9258
Popis: Metabolic dysfunction is a major driver of tumorigenesis. The serine/threonine kinase mechanistic target of rapamycin (mTOR) constitutes a key central regulator of metabolic pathways promoting cancer cell proliferation and survival. mTOR activity is regulated by metabolic sensors as well as by numerous factors comprising the phosphatase and tensin homolog/PI3K/AKT canonical pathway, which are often mutated in cancer. However, some cancers displaying constitutively active mTOR do not carry alterations within this canonical pathway, suggesting alternative modes of mTOR regulation. Since DEPTOR, an endogenous inhibitor of mTOR, was previously found to modulate both mTOR complexes 1 and 2, we investigated the different post-translational modification that could affect its inhibitory function. We found that tyrosine (Tyr) 289 phosphorylation of DEPTOR impairs its interaction with mTOR, leading to increased mTOR activation. Using proximity biotinylation assays, we identified SYK (spleen tyrosine kinase) as a kinase involved in DEPTOR Tyr 289 phosphorylation in an ephrin (erythropoietin-producing hepatocellular carcinoma) receptor–dependent manner. Altogether, our work reveals that phosphorylation of Tyr 289 of DEPTOR represents a novel molecular switch involved in the regulation of both mTOR complex 1 and mTOR complex 2.
Databáze: OpenAIRE